-
Recent Posts
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
- Timeless Good Advice? (Action for Happiness)
- The Diversionary Value of Music Playlists for Patients With Dementia in Accident and Emergency Settings (Nurses.co.uk / BBC News)
Archives
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Dopamine
Parkinson’s Disease Awareness Week 2017 (BBC News / Nature Biotechnology / Parkinson’s UK)
Summary Researchers hope one day to be able to replace the damaged dopamine-producing neurons at the root-cause of by Parkinson’s Disease by injecting new replacement brain cells, possibly derived from re-programmed astrocytes. Full Text Link Reference Brain cell therapy ‘promising’ … Continue reading
Posted in Animal Studies, BBC News, Charitable Bodies, In the News, International, Person-Centred Care, Quick Insights, UK, Universal Interest
Tagged Ageing Population, Astrocytes, Austria, Awareness and Campaigns, Awareness and Understanding, Awareness Campaigns, Awareness Raising, BBC Health News, Biomedical Research Institute of Malaga (IBIMA), Cell Replacement Therapy for Neurodegenerative Diseases, Center for Brain Research: Medical University of Vienna, Department of Medical Biochemistry and Biophysics: Karolinska Institutet, Department of Molecular Neurosciences: Medical University of Vienna, Department of Neuroscience: Karolinska Institutet, Department of Pharmacology: Malaga University, Dopamine, Dopamine Neuron Degeneration, Faculty of Medicine: Malaga University, Induced Dopamine Neurons (iDANs), Induced Neurons (iNs), Induced Pluripotent Stem (iPS) Cells, Karolinska Institute, Karolinska Institute in Stockholm, Karolinska Institutet, Laboratory of Molecular Neurobiology: Karolinska Institutet, Malaga University, Medical University of Vienna, Midbrain Dopamine Neurons (mDAs), Nature Biotechnology (Journal), Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Parkinson's Awareness Month, Parkinson's Awareness Week, Parkinson’s Awareness Week (2017), Parkinson’s Disease Awareness Week (2017), Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Professor David Dexter: Parkinson's UK, Spain Institute for Stem Cell Biology and Regenerative Medicine: Stanford University, Stanford University, Substantia Nigra, Sweden, United States, USA, World Parkinson’s Day
Leave a comment
Lancet Seminar on Parkinson’s Disease (Lancet / Advances in Integrative Medicine / Translational Proteomics / Parkinson’s UK / BBC News)
Summary Coinciding with Parkinson’s Awareness Week 2015 (April 20th – 26th 2015), the following Lancet review / seminar covers the clinical features, risk factors, pathology, genetics, pathogenesis, diagnosis and treatment of Parkinson’s Disease. Full Text Link (Note: This article requires … Continue reading
Posted in Acute Hospitals, BBC News, Charitable Bodies, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Non-Pharmacological Treatments, Parkinson's Disease, Pharmacological Treatments, Quick Insights, Scotland, Systematic Reviews, UK, Universal Interest
Tagged Abnormal Prion Protein, Abnormal Proteins (Alpha-Synuclein), Abnormal Proteins (Prions), Acting Out Dreams: Rapid Eye Movement (REM) Sleep Behaviour Disorder, Advances in Integrative Medicine, Association of RBD with Synucleinopathies, BBC Health News, Biomarkers, Braak Model, Braak Staging of Lewy Pathology in Parkinson’s Disease, Canada, CHCHD2, CIND-PD: Cognitive Impairment in Parkinson's Disease, Clinical Symptoms and Time Course of Parkinson’s Disease Progression, Complications of Dopaminergic Therapies for Parkinson’s Disease, Deep Brain Stimulation (DBS), Dementia in Parkinson's Disease, Department of Human Protein Sciences: Geneva University Hospitals, Department of Neurology: Geneva University Hospitals, DNAJC13, Dopamine, Dopamine Replacement Therapy (DRT), Dreaming in Dementia: REM Sleep Behaviour Disorder and Synucleinopathy, Drug Treatments for Parkinson’s Disease, Early Parkinson Disease, Edmond J Safra Program in Parkinson’s Disease: Toronto Western Hospital, EIF4G1, Faculty of Medicine: Geneva University Hospitals, Falls in Parkinson's Disease, Genetics of Parkinson's Disease, Geneva University Hospitals, Institute of Neurological Sciences in Glasgow, α-Synuclein, α-Synuclein Aggregation, Lancet, Lewy Body Parkinson Disease, LRRK2, LRRK2: Leucine-Rich Repeat Kinase 2 Gene, Monogenic Forms of Parkinson’s Disease (By Gene), Morton and Gloria Shulman Movement Disorders Clinic: Toronto Western Hospital, National Deep Brain Stimulation Service for Scotland, National Service in Scotland: NHS DBS Centres in Scotland, National Specialist Services Committee (Scotland), Neuroproteomics Group: Geneva University Hospitals, NHS DBS Centres in England, Non-Motor Fluctuations in Parkinson's Disease, Parkin (PARK2), Parkinson's Awareness Week, Parkinson’s Awareness Week (2015), Parkinson’s Disease Awareness Week (2015), Parkinson’s Disease Dementia, Parkinson’s Disease Diagnosis, Parkinson’s Disease Pathogenesis, Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Parkinson’s-Like Symptoms, Parkinsonian Symptoms, Parkinsonism, PDD: Parkinson's Disease with Dementia, Prion Diseases, Prion Protein, Proteomic Profiling of Parkinson's Disease-Relevant Brain Regions, Proteomics, Rapid Eye Movement (REM) Sleep Behaviour Disorder, Rapid Eye Movement (REM) Sleep Disorder, Rapid Eye Movement Sleep Behaviour Disorder (RBD), RBD: Rapid Eye Movement Sleep Behaviour Disorder, SNCA, SNCA: α-Synuclein Gene, Switzerland, Synucleinopathies, Synucleinopathy, Toronto Western Hospital, Translational Proteomics, UK Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria, University Medical Center: Geneva University Hospitals, University of Toronto, VPS35
Leave a comment
Future Stem Cell Therapy for Parkinson’s Disease? (BBC News / Cell Stem Cell)
Summary Researchers at Lund University in Sweden, working with rats, have claimed a potential breakthrough in how stem cell-derived dopamine-producing brain cells might, in future, be used to repair the damage in the brain caused by Parkinson’s Disease. This is … Continue reading
Posted in Animal Studies, BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Parkinson's Disease, Quick Insights, Universal Interest
Tagged BBC Health News, Cell Stem Cell (Journal), Collaborative Projects, Collaborative Research, Commissariat à l’Energie Atomique (CEA), Department of Experimental Medical Science: Lund University, Developmental and Regenerative Neurobiology, Dopamine, ESC-Derived Dopamine Neurons, EU Network TRANSEURO, EU Networks NeuroStemCell and NeuroStemcellRepair, hESC-Derived Midbrain Dopamine Neurons (Rat Model), Human Embryonic Stem Cells (hESCs), Human ESC-Derived Dopamine Neurons, I-Stem: AFM (France), Inserm U861, International Collaborations, Lund Stem Cell Center, Lund University, MIRCen in Paris, Molecular Imaging Research Centre (MIRCen), Neural Stem Cells (NSCs), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Rat Model of Parkinson’s Disease, Stem Cell Research, Stem Cell Research and Therapy, Stem Cell Therapy for Parkinson's Disease, Stem Cell-Derived Brain Cells, Stem Cells, Sweden, Transplantable Dopamine Neurons, Transplants of hESC-DA, Wallenberg Neuroscience Center: Lund University
Leave a comment
Parkinson’s Disease Awareness Week 2014 (Parkinson’s UK)
Summary This is Parkinson’s Awareness Week (April 7th – 13th 2014), which presents an opportunity for people to become involved, and to help raise awareness about Parkinson’s Disease and about the activities of Parkinson’s UK. Parkinson’s Disease: Information for Community Pharmacists … Continue reading
Posted in Charitable Bodies, Community Care, In the News, Integrated Care, National, Parkinson's Disease, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, UK, Universal Interest
Tagged Adherence to Medication Routines, Anti-Emetics, Anticholinergics, Awareness and Understanding, Awareness Raising, Catechol-O-Methyl Transferase Inhibitors, Community Pharmacists, Dopamine, Dopamine Agonists, Drug Side-Effects, Drug Treatments for Parkinson’s Disease, Get It On Time Campaign, Glutamate Antagonist, Harm From Omitted and Delayed Medicines, Local Parkinson’s Disease Experts, Local Pharmacy Services, MAR (Medication Administration Records), Medication Administration Records, Medicines Management, Medicines Optimisation, Medicines to Avoid (Parkinson's Disease), Medicines Use Review (MUR), Monoamine-Oxidase B Inhibitors, Neurological Disorders, Parkinson's Awareness Week, Parkinson’s Awareness Week (2014), Parkinson’s Disease: for Community Pharmacists, Parkinson’s Specialists, Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Parkinsonian Symptoms, Pharmacists, Prescribed Medication Routines, Self-Administration, Supporting People With Hospital Admissions, Timely and Accurate Medication, Timing, Wearing Off
Leave a comment
Parkinson’s Disease: Information for Hospital Pharmacists (Parkinson’s UK)
Summary This brief guide from Parkinson’s UK has been released for hospital pharmacists (and other healthcare professionals) as an aid to improve awareness and education about the condition. This booklet is aimed at hospital pharmacists, but another guide for community … Continue reading
Posted in Charitable Bodies, National, Parkinson's Disease, Pharmacological Treatments, Practical Advice, Quick Insights, UK, Universal Interest
Tagged Anti-Emetics, Anticholinergics, Awareness and Understanding, Awareness Raising, Catechol-O-Methyl Transferase Inhibitors, Dopamine, Dopamine Agonists, Drug Charts, Get It On Time Campaign, Glutamate Antagonist, Harm From Omitted and Delayed Medicines, Hospital Pharmacists, Levodopa, Medicines Management, Medicines Management Audits, Medicines Optimisation, Medicines to Avoid (Parkinson's Disease), Monoamine-Oxidase B Inhibitors, National Patient Safety Agency (NPSA), Neurological Disorders, NICE Guideline on Parkinson’s Disease, Parkinson's Awareness Week, Parkinson’s Awareness Week (2014), Parkinson’s Disease: for Hospital Pharmacists, Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Parkinsonian Symptoms, Pharmacists, Pill Timers, Self-Administration, SIGN Guideline on Parkinson’s Disease, Timely and Accurate Medication, Wearing Off
Leave a comment
Fungal Mould Implicated in Parkinson’s Disease? (NHS Choices / Proceedings of the National Academy of Sciences of the United States of America)
Summary A recent NHS Choices critical appraisal has covered research which has been misunderstood by the media as implying that living in mouldy environments can increase the risk of developing Parkinson’s Disease. Researchers exposed fruit flies to 1-octen-3-ol; a molecule … Continue reading
Posted in Animal Studies, For Doctors (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights
Tagged Behind the Headlines, Critical Appraisals, Department of Plant Biology and Pathology: Rutgers, Dopamine, Dopamine Neuron Degeneration, Drosophila melanogaster, Fruit Flies, Fungal Mould, Fungal-Derived Semiochemical 1-octen-3-ol, Human Plasma Membrane Dopamine Transporter (DAT), Mould, Mouldy Environments, National Institutes of Health (NIH), Neurodegeneration, New Brunswick and Emory University, Parkinsonism, Proceedings of the National Academy of Sciences (PNAS), Proceedings of the National Academy of Sciences of the United States of America (PNAS), Risk Factors, Rutgers University Research Fund, Rutgers: State University of New Jersey, Tyrosine Hydroxylase, United States, USA, Vesicular Monoamine Transporter (VMAT), VMAT2, Volatile Fungal Semiochemical 1-octen-3-ol
Leave a comment
